Does once-daily dosing prevent nephrotoxicity in all aminoglycosides equally?

This publication has 43 references indexed in Scilit:

• Editorial Response: Single Daily Dosing of Aminoglycosides--A Concept Whose Time Has Not Yet Come
  Clinical Infectious Diseases, 1997
• Once-Daily Aminoglycoside Dosing: Impact on Requests and Costs for Therapeutic Drug Monitoring
  Therapeutic Drug Monitoring, 1996
• A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses
  Journal of Antimicrobial Chemotherapy, 1996
• Ototoxicity and nephrotoxicity of gentamicin vs netilmicin in patients with serious infections. A randomized clinical trial
  Clinical Otolaryngology, 1995
• Once-daily gentamicin versus once-daily netilmicin in patients with serious infections—a randomized clinical trial
  Journal of Antimicrobial Chemotherapy, 1994
• Incidence of and Significant Risk Factors for Aminoglycoside-Associated Nephrotoxicity in Patients Dosed by Using Individualized Pharmacokinetic Monitoring
  The Journal of Infectious Diseases, 1993
• The Influence of Tobramycin Dosage Regimens on Nephrotoxicity, Ototoxicity, and Antibacterial Efficacy in a Rat Model of Subcutaneous Abscess
  The Journal of Infectious Diseases, 1988
• Serum Level Monitoring of Antibacterial Drugs
  Clinical Pharmacokinetics, 1984
• The Pathology of Acute Renal Failure Due to Interstitial Nephritis in Man with Comments on the Role of Interstitial Inflammation and Sex in Gentamicin Nephrotoxicity
  Medicine, 1982
• The Influence of Dosage Regimen on Experimental Gentamicin Nephrotoxicity: Dissociation of Peak Serum Levels from Renal Failure
  The Journal of Infectious Diseases, 1979